Cargando…
Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform
OBJECTIVES: In 2009, the Chinese government launched a national healthcare reform programme aiming to control healthcare expenditure and increase the quality of care. As part of this programme, a new drug pricing reform was initiated on 1 June 2015. The objective of this study was to describe the ch...
Autores principales: | Chen, Yixi, Hu, Shanlian, Dong, Peng, Kornfeld, Åsa, Jaros, Patrycja, Yan, Jing, Ma, Fangfang, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802695/ https://www.ncbi.nlm.nih.gov/pubmed/27123191 http://dx.doi.org/10.3402/jmahp.v4.30458 |
Ejemplares similares
-
The Short-Term Impact of Ontario's Generic Pricing Reforms
por: Law, Michael R., et al.
Publicado: (2011) -
The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China
por: Zhang, Xiaoxi, et al.
Publicado: (2020) -
Reforming a Reformer
Publicado: (1877) -
Interest Groups' Influence over Drug Pricing Policy Reform in South Korea
por: Chung, Woojin, et al.
Publicado: (2005) -
Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China
por: Lin, Taoyu, et al.
Publicado: (2020)